SEC Form 4 · accession 0001415889-15-002844
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leslie L Iversen
Director
Period of report
Aug 19, 2015
Accepted (ET)
Aug 21, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2015 | M | 8,500 | $11.00 | A | 36,127 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $11.00 | Aug 19, 2015 | M | 8,500 | D | — | Sep 8, 2015 | Common Stock | 8,500 | 0 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of September 9, 2005.